OVID - Ovid Therapeutics Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

OVID is currently covered by 1 analysts with average potential upside of $4.3 (86.95%) backed by 13 price targets and 12 ratings. Documented since 14-Jul-2020. Analyst's average stock valuation to be materialised ratio is 7.14% with an average time for price targets to be met of 45.5 days.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2022.

Highest price target for OVID is 4, Lowest price target is 2, average price target is 3.

Best performing analysts who are covering OVID - Ovid Therapeutics Inc:

Yigal Nochomovitz Brian Abrahams

Currently, out of the existing stock ratings of OVID - 3 which are a Hold (100%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



6 months 26 days ago

1/7 (14.29%)

$2.09 (48.60%)




2 years 24 days ago

0/2 (0%)

$6.5 (125.30%)

Show more analysts

What is OVID(Ovid Therapeutics Inc) average time for price targets to be met?

On average it took 45.5 days on average for the stock forecasts to be realized with a an average price target met ratio 7.14

Which analyst has the current highest performing score on OVID(Ovid Therapeutics Inc) with a proven track record?